| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the School of Hygiene and Public Health (E.A. Childs and Drs. Lyles, Chen, and McArthur) and the School of Medicine (Drs. Selnes and McArthur), The Johns Hopkins University, Baltimore, MD; UCLA Neuropsychiatric Institute (Dr. Miller), Los Angeles, CA; Department of Neurology (Dr. Cohen), Northwestern University, Chicago, IL; and the School of Medicine (Dr. Becker) and the Graduate School of Public Health (Dr. Mellors), University of Pittsburgh, PA.
Address correspondence and reprint requests to Dr. Justin McArthur, Johns Hopkins Hospital, 600 N. Wolfe Street, Meyer 6-109, Baltimore, MD 21287-7609.
OBJECTIVE: To determine the predictive value of plasma HIV RNA and CD4 lymphocytes for HIV-associated dementia and sensory neuropathy.
METHODS: A total of 1,604 AIDS-free HIV seropositive men from the Multicenter AIDS Cohort Study were followed over a 10-year period (1985 to 1995). HIV-associated dementia and sensory neuropathy were diagnosed according to standard definitions. Baseline samples were used to measure plasma HIV RNA levels with a branched DNA assay and levels of ß2-microglobulin, CD4 lymphocyte counts, and hemoglobin levels.
RESULTS: Seventy-seven patients with HIV-associated dementia and 213 patients with sensory neuropathy were identified. Baseline HIV RNA levels above 3,000 copies/mL and CD4 counts below 500 cells/mm3 were predictive of both neurologic outcomes, but neither hemoglobin, body mass index, nor ß2-microglobulin were independently predictive. After adjusting for age and level of education, individuals with baseline plasma HIV RNA >30,000 copies/mL had a relative hazard for dementia 8.5 times (p < 0.001) that of those with <3,000 copies/mL, and those with CD4 counts <200 cells/mm3 had a 3.5-fold (p = 0.003) greater hazard relative to those with CD4 counts >500 cells/mm3. Individuals with HIV RNA >10,000 copies/mL had a 2.3-fold (p = 0.008) greater hazard of sensory neuropathy than those with <500 copies/mL, and men with <750 CD4 cells/mm3 had a 1.4-fold (p = 0.03) greater hazard than those with >750 CD4 cells/mm3.
CONCLUSIONS: High levels of systemic HIV replication may "drive" the initiation of neurologic disease; effective suppression of HIV may reduce the incidence of dementia and neuropathy. Levels of plasma HIV RNA and CD4 counts, determined before the initiation of antiretroviral therapy, were predictive of HIV-associated dementia and sensory neuropathy.
This article has been cited by other articles:
|
|
 |
|
  M. I. Johnston and A. S. Fauci An HIV Vaccine -- Evolving Concepts N. Engl. J. Med., May 17, 2007; 356(20): 2073 - 2081. [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Wong, K. Robertson, N. Nakasujja, R. Skolasky, S. Musisi, E. Katabira, J. C. McArthur, A. Ronald, and N. Sacktor Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa Neurology, January 30, 2007; 68(5): 350 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Simpson, D. Kitch, S. R. Evans, J. C. McArthur, D. M. Asmuth, B. Cohen, K. Goodkin, M. Gerschenson, Y. So, C. M. Marra, et al. HIV neuropathy natural history cohort study: Assessment measures and risk factors Neurology, June 13, 2006; 66(11): 1679 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Cherry, R. L. Skolasky, L. Lal, J. Creighton, P. Hauer, S. P. Raman, R. Moore, K. Carter, D. Thomas, G. J. Ebenezer, et al. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort Neurology, March 28, 2006; 66(6): 867 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schifitto, M. P. McDermott, J. C. McArthur, K. Marder, N. Sacktor, D. R. McClernon, K. Conant, B. Cohen, L. G. Epstein, K. Kieburtz, et al. Markers of immune activation and viral load in HIV-associated sensory neuropathy Neurology, March 8, 2005; 64(5): 842 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Sevigny, S. M. Albert, M. P. McDermott, J. C. McArthur, N. Sacktor, K. Conant, G. Schifitto, O. A. Selnes, Y. Stern, D. R. McClernon, et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia Neurology, December 14, 2004; 63(11): 2084 - 2090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. McArthur, M. P. McDermott, D. McClernon, C. St Hillaire, K. Conant, K. Marder, G. Schifitto, O. A. Selnes, N. Sacktor, Y. Stern, et al. Attenuated Central Nervous System Infection in Advanced HIV/AIDS With Combination Antiretroviral Therapy Arch Neurol, November 1, 2004; 61(11): 1687 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Morgello, L. Estanislao, D. Simpson, A. Geraci, A. DiRocco, P. Gerits, E. Ryan, T. Yakoushina, S. Khan, R. Mahboob, et al. HIV-Associated Distal Sensory Polyneuropathy in the Era of Highly Active Antiretroviral Therapy: The Manhattan HIV Brain Bank Arch Neurol, April 1, 2004; 61(4): 546 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Ragin, P. Storey, B. A. Cohen, L. G. Epstein, and R. R. Edelman Whole Brain Diffusion Tensor Imaging in HIV-Associated Cognitive Impairment AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Marcotte, R. Deutsch, J. A. McCutchan, D. J. Moore, S. Letendre, R. J. Ellis, M. R. Wallace, R. K. Heaton, and I. Grant Prediction of Incident Neurocognitive Impairment by Plasma HIV RNA and CD4 Levels Early After HIV Seroconversion Arch Neurol, October 1, 2003; 60(10): 1406 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schifitto, M. P. McDermott, J. C. McArthur, K. Marder, N. Sacktor, L. Epstein, K. Kieburtz, and the Dana Consortium on the Therapy of HIV Dementia Incidence of and risk factors for HIV-associated distal sensory polyneuropathy Neurology, June 25, 2002; 58(12): 1764 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Tyler and J. C. McArthur Through a Glass, Darkly: Cerebrospinal Fluid Viral Load Measurements and the Pathogenesis of Human Immunodeficiency Virus Infection of the Central Nervous System Arch Neurol, June 1, 2002; 59(6): 909 - 912. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Ellis, D. J. Moore, M. E. Childers, S. Letendre, J. A. McCutchan, T. Wolfson, S. A. Spector, K. Hsia, R. K. Heaton, I. Grant, et al. Progression to Neuropsychological Impairment in Human Immunodeficiency Virus Infection Predicted by Elevated Cerebrospinal Fluid Levels of Human Immunodeficiency Virus RNA Arch Neurol, June 1, 2002; 59(6): 923 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. De Ronchi, I. Faranca, D. Berardi, P. Scudellari, M. Borderi, R. Manfredi, and L. Fratiglioni Risk Factors for Cognitive Impairment in HIV-1-Infected Persons With Different Risk Behaviors Arch Neurol, May 1, 2002; 59(5): 812 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Patel, D. L. Kolson, G. Glosser, I. Matozzo, Y. Ge, J. S. Babb, L. J. Mannon, and R. I. Grossman Correlation between Percentage of Brain Parenchymal Volume and Neurocognitive Performance in HIV-Infected Patients AJNR Am. J. Neuroradiol., April 1, 2002; 23(4): 543 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tang, B. Shelton, N. J. Makhatadze, Y. Zhang, M. Schaen, L. G. Louie, J. J. Goedert, E. C. Seaberg, J. B. Margolick, J. Mellors, et al. Distribution of Chemokine Receptor CCR2 and CCR5 Genotypes and Their Relative Contribution to Human Immunodeficiency Virus Type 1 (HIV-1) Seroconversion, Early HIV-1 RNA Concentration in Plasma, and Later Disease Progression J. Virol., January 15, 2002; 76(2): 662 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Polydefkis, C.T. Yiannoutsos, B.A. Cohen, H. Hollander, G. Schifitto, D.B. Clifford, D.M. Simpson, D. Katzenstein, S. Shriver, P. Hauer, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy Neurology, January 8, 2002; 58(1): 115 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ferrarese, A. Aliprandi, L. Tremolizzo, L. Stanzani, A. De Micheli, A. Dolara, and L. Frattola Increased glutamate in CSF and plasma of patients with HIV dementia Neurology, August 28, 2001; 57(4): 671 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sacktor, P. M. Tarwater, R. L. Skolasky, J. C. McArthur, O. A. Selnes, J. Becker, B. Cohen, and E. N. Miller CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing Neurology, August 14, 2001; 57(3): 542 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Stern, M. P. McDermott, S. Albert, D. Palumbo, O. A. Selnes, J. McArthur, N. Sacktor, G. Schifitto, K. Kieburtz, L. Epstein, et al. Factors Associated With Incident Human Immunodeficiency Virus-Dementia Arch Neurol, March 1, 2001; 58(3): 473 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maschke, O. Kastrup, S. Esser, B. Ross, U. Hengge, and A. Hufnagel Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART) J. Neurol. Neurosurg. Psychiatry, September 1, 2000; 69(3): 376 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. d. Q. C. Araújo, O. J. M. Nascimento, and O. S. Garcia Distal Sensory Polyneuropathy in a Cohort of HIV-Infected Children Over Five Years of Age Pediatrics, September 1, 2000; 106(3): 35e - 35. [Abstract] [Full Text]
|
|
|
|
|
|
A. Di Rocco, A. Geraci, M. Tagliati, R. Staudinger, and K. Henry Remission of HIV myelopathy after highly active antiretroviral therapy Neurology, August 8, 2000; 55(3): 456 - 456. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Berger and G. Arendt HIV dementia: the role of the basal ganglia and dopaminergic systems J Psychopharmacol, May 1, 2000; 14(3): 214 - 221. [Abstract] [PDF]
|
|
|
|
|
|
D. McGuire and K. Marder Pharmacological frontiers in the treatment of AIDS dementia J Psychopharmacol, May 1, 2000; 14(3): 251 - 257. [Abstract] [PDF]
|
|
|
|
 |
|
 R. IIDA, K. SAITO, K. YAMADA, A. S. BASILE, K. SEKIKAWA, M. TAKEMURA, H. FUJII, H. WADA, M. SEISHIMA, and T. NABESHIMA Suppression of neurocognitive damage in LP-BM5-infected mice with a targeted deletion of the TNF-{alpha} gene FASEB J, May 1, 2000; 14(7): 1023 - 1031. [Abstract] [Full Text]
|
|
|
|
|
|
D. B. Clifford Human Immunodeficiency Virus-Associated Dementia Arch Neurol, March 1, 2000; 57(3): 321 - 324. [Full Text] [PDF]
|
|
|
|
|
|
L. Chang, T. Ernst, M. Leonido-Yee, and O. Speck Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex Neurology, January 25, 2000; 54(2): 389 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Plasma Viral Load Predicts HIV-Associated Dementia Journal Watch Neurology, June 1, 1999; 1999(601): 3 - 3. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
